Company has raised $112m in order to develop therapies for central nervous system disorders Company has raised $112m in order to develop therapies for central nervous system disorders Noema Pharma – a ...

First new treatment approved for Alzheimer’s disease in over a decade The US Food and Drug Administration (FDA) has granted Biogen and Eisai’s aducanumab and accelerated approval, making it the first ...

We can now create synthetic human embryos – embryoids – from stem cells, without the need for sperm or eggs. Published in Nature in September, a research group from the Weizmann Institute in Israel ...

On Saturday a record 371,339 booster jabs were administered, but the government has warned that COVID restrictions may be implemented to combat waning resistance, and an 8% increase in weekly COVID ...

The aggressive brain cancer is responsible for over 3,000 cases in the UK every year Researchers from King’s College London (KCL) have developed an artificial intelligence (AI)-based model that can ...

The European Union has announced it is to give The University of St Andrews 4.37 million Euros for a medical data study. The University of St Andrews has secured funding of 4.37 million Euros from the ...

The European Commission has approved IMS Health’s plans to acquire part of France-based Cedegim SA’s customer relationship management and strategic data business, but with conditions. The European ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe's first in vivo genome editing study. The Medicines and Healthcare Products Regulatory ...

The US Food and Drug Administration is allowing onto the market the first new hepatitis B vaccine in more than 25 years with the approval of Dynavax’ Heplisav-B. The US Food and Drug Administration is ...

The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the ...

The monoclonal antibody combination is being tested for prevention and treatment of coronavirus AstraZeneca has dosed the first participants in a Phase I trial of AZD7442, a combination of two ...

Steve Broadhurst is joining advertising and communications agency 11 London as creative director, bringing more than 20 years experience of healthcare and not-for-profit campaigns. Steve was ...